46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03435601 (ClinicalTrials.gov)	April 18, 2018	31/1/2018	A Study to Target the Type I IFN Receptor by Administrating Anifrolumabin RA Patients With a High IF ...	A Randomised, Double-blind, Placebo-controlled Phase II Study to Target the Type I IFN Receptor by A ...	Rheumatoid Arthritis	Drug: Anifrolumab;Drug: Placebos	Josef Smolen, Univ. Prof. Dr.	NULL	Recruiting	18 Years	70 Years	All	24	Phase 2	Austria
2	EUCTR2017-001717-92-AT (EUCTR)	11/12/2017	17/08/2017	A randomised, double-blind, placebo-controlled Phase II study to target the type I IFN receptor by a ...	A randomised, double-blind, placebo-controlled Phase II study to target the type I IFN receptor by a ...	High IFN siganture in patients with rheumatoid arthritis MedDRA version: 20.0;Level: PT;Classificati ...	Product Name: Anifrolumab (MEDI-546) INN or Proposed INN: ANIFROLUMAB Other descriptive name: ANIFROLUM ...	Medical University of Vienna	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Austria;Switzerland;Italy

First Previous1Next Last